Annals of Medicine commentary examines plasma metabolomics in Northwest China celiac patients—what the blood-chemistry findings mean for future diagnosis.
New research follows children with positive celiac tests but no intestinal damage — and finds outcomes vary widely among kids with potential celiac disease.
A new review identifies exosomes as key players in celiac disease, with potential as non-invasive biomarkers for diagnosis and targets for new treatments.
New research identifies molecules that could neutralize gluten before it triggers immune damage—what this means for celiac families.
New research reveals intestinal cells actively contribute to celiac disease onset, not just suffer damage. What this means for prevention and treatment.
Italian study finds denosumab effectively increases bone density in celiac patients with osteoporosis, offering hope for those at high fracture risk.
New research explores how genetic variations in antibody genes may influence the immune response in celiac disease, offering clues for future treatments.
Columbia study finds kissing after gluten consumption poses minimal risk. Drinking water first eliminates detectable gluten transfer entirely.
New research reveals what helps celiac patients stick to their gluten-free diet—and the barriers that make adherence so difficult.
New genetic research suggests celiac disease may be linked to lower Alzheimer's risk. What this means for celiac families and future research.
University of Cincinnati research reveals gut microbiome differences may influence celiac disease development, offering new clues for prevention.
Scientists discover specialized intestinal cells that play a key role in triggering the celiac immune response, opening potential new paths for treatment.
A major review outlines promising celiac disease treatments in development, from gluten-digesting enzymes to immune tolerance therapies.
The DAISY Study is recruiting adults with celiac disease who have symptoms despite a gluten-free diet. Travel compensation included.
UC Davis researchers used gene editing to remove gluten proteins harmful to people with celiac disease. Here's what this breakthrough could mean for families.
The Celiac Disease Foundation's new $15M Impact Fund could accelerate innovations in detection, treatment, and food safety for celiac families.